Antiangiogenesis: New Frontiers in Therapeutic Development--IBC's Fourth Annual International Symposium.
Harris
Randall E
RE
Ohio State University Medical Center, Division of Epidemiology, 320 West 10th Avenue, A-150B Starling Loving Hall, Columbus, OH 43210, USA. Harris.44@osu.edu
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D052246:Cyclooxygenase 2 Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
D020533:Angiogenesis Inhibitors; D052246:Cyclooxygenase 2 Inhibitors; D042461:Vascular Endothelial Growth Factor A